ARCHIVES

FDA To Regulate Products From Human Cells, Tissue

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

Stand Up To Cancer Selects Five Groups For “Dream Team” Grants Totaling $73.6M.

May 29, 2009

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

McKenna Sees Budget Cuts as Threat to Year 2000 Goals Urges Stepped Up Efforts Against Tobacco Industry

April 5, 1985

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990